NGeneBio Co Ltd
KOSDAQ:354200
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
N
|
NGeneBio Co Ltd
KOSDAQ:354200
|
KR |
|
C
|
CYL Corp Bhd
KLSE:CYL
|
MY |
|
Okea ASA
F:3SX
|
NO |
|
L
|
Laguna Resorts and Hotels PCL
SET:LRH
|
TH |
|
Blackstone Minerals Ltd
ASX:BSX
|
AU |
|
Red Rock Resorts Inc
F:RRK
|
US |
|
K
|
Kancera AB
F:3EE0
|
SE |
|
B
|
Big Ridge Gold Corp
OTC:ALVLF
|
CA |
|
N
|
Next Generation Management Corp
OTC:NGMC
|
US |
|
F
|
First Growth Funds Ltd
CNSX:FGFL
|
AU |
|
Verano Holdings Corp
OTC:VRNO
|
US |
|
T
|
TSG Star Travel Corp
TPEX:2719
|
TW |
|
Fernhill Corp
OTC:FERN
|
US |
|
N
|
Nulegacy Gold Corp
F:7NU
|
CA |
|
M
|
Mansoon Trading Co Ltd
BSE:512303
|
IN |
|
Future Retail Ltd
NSE:FRETAIL
|
IN |
|
T
|
Thunderbird Entertainment Group Inc
OTC:THBRF
|
CA |
|
C
|
Cartesian Growth Corporation II
NASDAQ:RENE
|
US |
|
Klingelnberg AG
SIX:KLIN
|
CH |
|
Kenadyr Mining Corp
XTSX:KEN
|
CA |
Bankruptcy Probability
NGeneBio Co Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
NGeneBio Co Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| KR |
N
|
NGeneBio Co Ltd
KOSDAQ:354200
|
27.8B KRW |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
456.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
236.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
184.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
138.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
83.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
56B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
82.5B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
NGeneBio Co Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, NGeneBio Co Ltd has total debt of 12.6B KRW. This includes both short-term (12.5B KRW) and long-term (109.2m KRW) debt.
You can find a full breakdown on its Balance Sheet.
